Aigen Investment Management’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-949
Closed -$26.2K 886
2024
Q3
$26.2K Buy
949
+54
+6% +$1.49K 0.01% 686
2024
Q2
$26K Buy
+895
New +$26K 0.01% 733
2024
Q1
Sell
-763
Closed -$29.6K 879
2023
Q4
$29.6K Buy
763
+60
+9% +$2.33K 0.01% 755
2023
Q3
$20.7K Buy
+703
New +$20.7K ﹤0.01% 783